Paloma Partners Management CO Ardelyx, Inc. Transaction History

Paloma Partners Management CO

  • $3.08 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$6.05 - $9.74 $71,323 - $114,824
11,789 New
11,789 $86,000
Q1 2020

May 15, 2020
SELL
$4.35 - $8.79 $62,874 - $127,050
-14,454 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$4.23 - $8.29 $61,140 - $119,823
14,454 New
14,454 $108,000
Q1 2019

May 15, 2019
SELL
$1.88 - $3.35 $69,184 - $123,280
-36,800 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$1.66 - $4.16 $61,088 - $153,088
36,800 New
36,800 $66,000

Others Institutions Holding ARDX

# of Institutions
219
Shares Held
141M
Call Options Held
1.08M
Put Options Held
2M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $815M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email